Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 8/20 | 0.33 |
| ▸ | CA2 | P00918 | 8/20 | 0.33 |
| ▸ | CA9 | Q16790 | 7/20 | 0.33 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.33 |
| ▸ | CA12 | O43570 | 3/20 | 0.33 |
| ▸ | CA7 | P43166 | 3/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.33 |
| ▸ | CA3 | P07451 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | CA6 | P23280 | 2/20 | 0.33 |
| ▸ | CA5A | P35218 | 2/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2555162 | 1.00 | OPRM1 (0.48) | OPRM1TP53SPHK1DNM1CA1 | |
| SCHEMBL14482046 | 1.00 | OPRM1 (0.48) | OPRM1TP53SPHK1DNM1CA1 | |
| SCHEMBL14482722 | 1.00 | OPRM1 (0.48) | OPRM1TP53SPHK1DNM1CA1 | |
| SCHEMBL2552500 | 1.00 | OPRM1 (0.48) | OPRM1TP53SPHK1DNM1CA1 | |
| SCHEMBL2141411 | 0.92 | OPRM1 (0.46) | OPRM1TP53SPHK1SLC2A1 | |
| SCHEMBL2142853 | 0.84 | OPRM1 (0.39) | OPRM1TP53 | |
| SCHEMBL375590 | 0.81 | LPAR2 (0.33) | OPRM1SPHK1DNM1LPAR2LPAR3 | |
| SCHEMBL375792 | 0.81 | LPAR2 (0.33) | OPRM1SPHK1DNM1LPAR2LPAR3 | |
| SCHEMBL375624 | 0.81 | LPAR2 (0.33) | OPRM1SPHK1DNM1LPAR2LPAR3 | |
| SCHEMBL375704 | 0.81 | LPAR2 (0.33) | OPRM1SPHK1DNM1LPAR2LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12570899-B2 | Bright silver based quaternary nanostructures | SHOEI CHEMICAL INC. (JP) | 2026-03-10 | — | — | US | disclosed |
| US-20240263069-A1 | BRIGHT SILVER BASED QUATERNARY NANOSTRUCTURES | SHOEI CHEMICAL INC. (JP) | 2024-08-08 | — | — | US | disclosed |
| US-11970646-B2 | Bright silver based quaternary nanostructures | SHOEI CHEMICAL INC. (JP) | 2024-04-30 | — | — | US | disclosed |
| CN-112724405-B | Curing agent mixture | 赢创运营有限公司 | 2024-01-30 | — | — | CN | disclosed |
| CN-115678542-A | Quaternary nanostructure based on bright silver | 纳米系统公司 | 2023-02-03 | — | — | CN | disclosed |
| EP-3816247-B1 | CURING MIXTURE | EVONIK OPERATIONS GMBH (DE) | 2022-12-07 | — | — | EP | disclosed |
| CN-113840895-B | Quaternary nanostructure based on bright silver | 纳米系统公司 | 2022-11-15 | — | — | CN | disclosed |
| US-20220228057-A1 | BRIGHT SILVER BASED QUATERNARY NANOSTRUCTURES | NANOSYS, INC. (US) | 2022-07-21 | — | — | US | disclosed |
| EP-3973033-A1 | BRIGHT SILVER BASED QUATERNARY NANOSTRUCTURES | Nanosys, Inc. (US) | 2022-03-30 | — | — | EP | disclosed |
| US-11254819-B2 | Curing agent mixture | EVONIK OPERATIONS GMBH (DE) | 2022-02-22 | — | — | US | disclosed |
| EP-3339387-A1 | COMPOUNDS BASED ON OF ADDUCTS WITH ISOCYANATES FOR COATING COMPOSITIONS | Evonik Degussa GmbH (DE) | 2018-06-27 | — | — | EP | disclosed |
| US-20160297974-A1 | ADDUCTS OF ISOCYANATOALKYLTRIMETHOXYSILANES WITH FLAME RETARDANTS REACTIVE THEREWITH | EVONIK DEGUSSA GMBH (DE) | 2016-10-13 | — | — | US | disclosed |
| US-20160108280-A1 | CROSSLINKING OF IPMS ADDUCTS WITH AMINOSILANES | EVONIK DEGUSSA GMBH (DE) | 2016-04-21 | — | — | US | disclosed |
| EP-2994495-A1 | CROSSLINKING OF IPMS ADDUCTS AND AMINOSILANES | Evonik Industries AG (DE) | 2016-03-16 | — | — | EP | disclosed |
| US-9266825-B2 | Copolymers of isocyanatoalkyltrialkoxysilanes and urethanediols | EVONIK DEGUSSA GMBH (DE) | 2016-02-23 | — | — | US | disclosed |
| EP-2552925-B1 | PROCESS FOR THE PREPARATION OF SILICON CONTAINING AZODICARBAMIDES | EVONIK DEGUSSA GMBH (DE) | 2014-07-23 | — | — | EP | disclosed |
| US-8664370-B2 | Process for preparing silicon-containing azodicarbamides | EVONIK DEGUSSA GMBH (DE) | 2014-03-04 | — | — | US | disclosed |
| EP-2552925-A1 | PROCESS FOR PREPARING SILICON-CONTAINING AZODICARBAMIDES | Evonik Degussa GmbH (DE) | 2013-02-06 | — | — | EP | disclosed |
| US-20130012691-A1 | Process for Preparing Silicon-Containing Azodicarbamides | EVONIK OPERATIONS GMBH (DE) | 2013-01-10 | — | — | US | disclosed |
| WO-2011120792-A1 | PROCESS FOR PREPARING SILICON-CONTAINING AZODICARBAMIDES | EVONIK DEGUSSA GMBH (DE) | 2011-10-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570899-B2 | Bright silver based quaternary nanostructures | LGALS3, ANXA3, ATXN2L | OPRM1 2012/4885TP53 286/4885SPHK1 4284/4885 |
| US-20130012691-A1 | Process for Preparing Silicon-Containing Azodicarbamides | C1R, CA9, CCNB3 | OPRM1 3084/4885TP53 2770/4885SPHK1 3772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.